Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00698828 · ClinicalTrials.gov registry record · Phase 2
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2 study, sponsored by Daiichi Sankyo.
- Completed
- Registry status
- Phase 2
- Development phase
- 227
- Enrollment target
NCT00698828 is a Phase 2 study that has completed, run by Daiichi Sankyo. The registered enrollment target is 227 participants.
The verdict
NCT00698828, a Phase 2 study, has completed, sponsored by Daiichi Sankyo.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 227 participants
- Enrollment target
Study Summary
To evaluate SUN11031 for subcutaneous injection compared to placebo in subjects with cachexia associated with Chronic Obstructive Pulmonary Disease (COPD) to determine the effect on physical performance and body composition.
Interventions
- DRUG Placebo comparator
- DRUG SUN11031 20 μg/kg
- DRUG SUN11031 40 μg/kg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 227 participants |
| Start Date | 2008-05-15 |
| Est. Completion | 2009-10-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00698828
The ClinicalTrials.gov registry entry for NCT00698828 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 227 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Daiichi Sankyo, which has 236 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo comparator is the first listed.
NCT00698828 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00698828 about?
NCT00698828 is a clinical study titled "SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)". To evaluate SUN11031 for subcutaneous injection compared to placebo in subjects with cachexia associated with Chronic Obstructive Pulmonary Disease (COPD) to determine the effect on physical performance and body composition.
What is the current status of trial NCT00698828?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 227 participants. The study started on 2008-05-15. Estimated completion is 2009-10-08.
What interventions are being tested in trial NCT00698828?
The interventions under investigation include: Placebo comparator (DRUG), SUN11031 20 μg/kg (DRUG), SUN11031 40 μg/kg (DRUG).
Who is sponsoring clinical trial NCT00698828?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.